FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093683 [Registered on: 26/08/2025] Trial Registered Prospectively
Last Modified On: 25/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   “COMPARING STANDARD TREATMENT AND PROBIOTICS FOR TREATING VAGINAL YEAST INFECTIONS” 
Scientific Title of Study   COMPARISON OF EFFICACY OF STANDARD AZOLE THERAPY FOR TREATMENT OF VAGINAL CANDIDAL INFECTION ALONE AND IN COMBINATION WITH PROBIOTICS 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Subhashini 
Designation  Postgraduate  
Affiliation  SRM medical college and hospital  
Address  Department of obstetrics and gynaecology SRM medical college ,hospital and research centre Potheri Kattankulathur
SRM medical college and hospital
Kancheepuram
TAMIL NADU
603203
India 
Phone  9443846272  
Fax    
Email  subhathangaraj080@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Sajeetha kumari 
Designation  Professor  
Affiliation  SRM medical college and hospital  
Address  SRM medical college and hospital Mahatma gandhi road Potheri Kattankulathur

Kancheepuram
TAMIL NADU
603203
India 
Phone  9940170195  
Fax    
Email  sajeethaprabhakar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Subhashini  
Designation  Postgraduate  
Affiliation  SRM medical college and hospital  
Address  Department of obstetrics and gynaecology SRM medical college ,hospital and research centre Potheri Kattankulathur

Kancheepuram
TAMIL NADU
603203
India 
Phone  9443846272  
Fax    
Email  subhathangaraj080@gmail.com  
 
Source of Monetary or Material Support  
SRM medical college ,hospital and research centre Potheri Kattankulathur Tamilnadu -603203 India  
 
Primary Sponsor  
Name  Subhashini  
Address  Department of obstetrics and gynaecology SRM medical college ,hospital and research centre Potheri Kattankulathur Tamilnadu India-603203 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Subhashini   SRM medical college, hospital and research centre   Room no -5 Department of obstetrics and gynaecology
Kancheepuram
TAMIL NADU 
9443846272

subhathangaraj080@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE, INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B373||Candidiasis of vulva and vagina,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Fluconazole   200mg per oral stat 
Intervention  Microflora   BD for 28days 
Comparator Agent  Placebo   Calcium tablets 500mg BD for 28days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Women in the reproductive age group
Presenting with vaginal discharge or itching or burning vaginal feeling or dysuria or dyspareunia
Evidence of positive candidial species by KOH mount by culture result
Willingness to participate  
 
ExclusionCriteria 
Details  Pregnancy, lactation, use of systemic or intravaginal antibiotic or antifungal agents cursor within the past 2 weeks,
Menstruation during sample collection
Postmenopausal women
Patients who are positive for bacterial vaginosis/trichomoniasis 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Look for vaginal discharge, itching, burning vaginal feeling, vaginal ph   Pretreatment followup, 14th day followup, 28th day followup  
 
Secondary Outcome  
Outcome  TimePoints 
Presence of candida by culture method   Pretreatment, 28th day followup  
 
Target Sample Size   Total Sample Size="84"
Sample Size from India="84" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Vulvovaginal candidiasis is a fundal infection that affects the vulva and vagina.
Aim- to compare the efficacy of standard anole therapy for treatment of vaginal candidiasis alone and in combination with probiotics 
Objectives- to compare the improvement of symptoms in both study and control groups, the compare the change in vaginal ph in both groups, to compare the culture growth in both the groups 
 
Close